Shahab Babakoohi, MD, describes the incidence patterns, options for testing and diagnosis, and risk stratification for basal cell carcinoma.
Back
Inside the Clinic: Basal Cell Carcinoma Treatment Advances
Jennifer Atlas, MD, and Shahab Babakoohi, MD, discuss advances in the treatment of patients with basal cell carcinoma and their treatment approaches to clinical scenarios based on updated data.
Inside the Clinic: Basal Cell Carcinoma Treatment Advances
Episodes
All
All
Jennifer Atlas, MD, presents the clinical scenario of a man with locally advanced basal cell carcinoma.
Dr. Shahab Babakoohi explains when to refer a patient with basal cell carcinoma from a dermatology practice to a medical oncologist.
Experts review the currently available treatment options for locally advanced basal cell carcinoma.
Dr Jennifer Atlas leads a conversation on systemic therapy options in basal cell carcinoma with a review of clinical trial data.
Shahab Babakoohi, MD, describes his monitoring strategies for patients with basal cell carcinoma.
Jennifer Atlas, MD, presents the case of a 66-year-old woman with locally advanced basal cell carcinoma not responding to frontline treatment.
Experts review the safety and toxicity data of anti-PD-1 antibody agent cemiplimab for basal cell carcinoma treatment.
A look at how common metastatic basal cell carcinoma is in clinical practice and when to consider frontline immunotherapy.
Drs Babakoohi and Atlas share clinical pearls for community oncologists on treating basal cell carcinoma.
Advertisement
Advertisement
Trending on OncLive
1
Ofirnoflast Elicits Durable Transfusion Independence, Hematologic Improvement in Lower-Risk MDS
2
Revumenib Plus Chemo Yields High Response and MRD-Negativity Rates in Newly Diagnosed NPM1+ or KMT2A+ AML
3
ACTIVE Regimen Elicits High Response Rates in R/R NPM1-Mutated AML
4
Dr Gangat on Phase 2 Efficacy and Safety Data for DISC-3405 in Polycythemia Vera
5